The epidemiology of severe sepsis in children in the United States

被引:575
作者
Watson, RS
Carcillo, JA
Linde-Zwirble, WT
Clermont, G
Lidicker, J
Angus, DC
机构
[1] Univ Pittsburgh, Dept Crit Care Med, CRISMA Lab, Ctr Res Hlth Care, Pittsburgh, PA 15261 USA
[2] LLC, Hlth Proc Management, Doylestown, PA USA
[3] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA
关键词
outcome; mortality; pediatrics; intensive care;
D O I
10.1164/rccm.200207-682OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Despite extensive research into the etiology and treatment of severe sepsis, little is known about its epidemiology in children. We sought to determine the age- and sex-adjusted incidence, outcome, and associated hospital costs of severe sepsis in United States children using 1995 hospital discharge and population data from seven states (24% of the United States population). Of 1,586,253 hospitalizations in children who were 19 years old or less, 9,675 met International Classification of Diseases, 9th revision, clinical modification-based severe sepsis criteria or 42,364 cases of pediatric severe sepsis per year nationally (0.56 cases per 1,000 population per year). The incidence was the highest in infants (5.16 per 1,000), fell dramatically in older children (0.20 per 1,000 in 10 to 14 year olds), and was 15% higher in boys than in girls (0.60 versus 0.52 per 1,000, p < 0.001). Hospital mortality was 10.3%, or 4,383 deaths nationally (6.2 per 100,000 population). Half of the cases had underlying disease (49.0%), and over one-fifth (22.9%) were low-birth-weight newborns. Respiratory infections (37%) and primary bacteremia (25%) were the most common infections. The mean length of stay and cost were 31 days and $40,600, respectively. Estimated annual total costs were $1.97 billion nationally. Severe sepsis is a significant health problem in children and is associated with the use of extensive healthcare resources. Infants are at highest risk, especially those with a low birth weight.
引用
收藏
页码:695 / 701
页数:7
相关论文
共 64 条
[1]  
*AM AC PED AM COLL, 1997, GUID PER CAR
[2]  
Angele MK, 1997, ARCH SURG-CHICAGO, V132, P1207
[3]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[4]   E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis - A randomized controlled trial [J].
Angus, DC ;
Birmingham, MC ;
Balk, RA ;
Scannon, PJ ;
Collins, D ;
Kruse, JA ;
Graham, DR ;
Dedhia, HV ;
Homann, S ;
MacIntyre, N .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (13) :1723-1730
[5]  
[Anonymous], AHRQ PUBLICATION
[6]  
[Anonymous], MMWR
[7]  
*APLS, PED EM MED COURS
[8]   Septicaemia in an Austrian neonatal intensive care unit:: a 7-year analysis [J].
Berger, A ;
Salzer, HR ;
Weninger, M ;
Sageder, B ;
Aspöck, C .
ACTA PAEDIATRICA, 1998, 87 (10) :1066-1069
[9]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[10]   TOWARD AN EPIDEMIOLOGY AND NATURAL-HISTORY OF SIRS (SYSTEMIC INFLAMMATORY RESPONSE SYNDROME) [J].
BONE, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (24) :3452-3455